Cited by 97Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain

Open access
Lien, Lillian F., Haqq, Andrea M., Arlotto, Michelle, Slentz, Cris A., Muehlbauer, Michael J., McMahon, Ross L., Rochon, James, Gallup, Dianne +9 more·2009·OMICS: A Journal of Integrative Biology

Abstract

The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) Project uses comprehensive metabolic profiling to probe biochemical mechanisms of weight loss in humans. Measurements at baseline, 2 and 4 weeks, 6 and 12 months included diet, body composition, metabolic rate, hormones, and 80 intermediary metabolites measured by mass spectrometry. In 27 obese adults in a behavioral weight loss intervention, median weight decreased 13.9 lb over the first 6 months, then reverted towards baseline by 12 months. Insulin resistance (HOMA) was partially ameliorated in the first 6 months and showed sustained improvement at 12 months despite weight regain. Ghrelin increased with weight loss and reverted to baseline, whereas leptin and PYY fell at 6 months and remained persistently low. NPY levels did not change. Factors possibly contributing to sustained improvement in insulin sensitivity despite weight regain include adiponectin (increased by 12 months), IGF-1 (increased during weight loss and continued to increase during weight regain), and visceral fat (fell at 6 months but did not change thereafter). We observed a persistent reduction in free fatty acids, branched chain amino acids, and related metabolites that may contribute to improved insulin action. These findings provide evidence for sustained benefits of weight loss in obese humans and insights into mechanisms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/omi.2008.0035

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lien, L. F., Haqq, A. M., Arlotto, M., Slentz, C. A., Muehlbauer, M. J., McMahon, R. L., Rochon, J., Gallup, D., Bain, J. R., Ilkayeva, O., Wenner, B. R., Stevens, R. D., Millington, D. S., Muoio, D. M., Butler, M. D., Newgard, C. B., & Svetkey, L. P.
Affiliations
  • Duke University (US)
  • Duke Medical Center (US)
Venue
OMICS: A Journal of Integrative Biology
Published
2009-02
Volume
13
Issue
1
Pages
21-35
ISSN
  • 1536-2310 (ISSN-L)
  • 1557-8100
OpenAlex
W2026855997
Cited by
97
References
59
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 3 · 2017: 13 · 2016: 5 · 2015: 8 · 2014: 6 · 2013: 14 · 2012: 6
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • OMICS A Journal of Integrative Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • GlaxoSmithKline
  • National Institutes of Health (5k23rr021979-02)
  • National Heart, Lung, and Blood Institute (U01HL068734)
  • National Center for Research Resources (1K23-RR-021979, K23-RR-021979)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
behavioral weight loss, weight regain, obesity, insulin resistance, HOMA, ghrelin, leptin, peptide YY, neuropeptide Y, adiponectin, insulin-like growth factor I, visceral fat, free fatty acids, branched-chain amino acids, intermediary metabolites, metabolite profiling, metabolic rate, body composition
MeSH terms
Adult, Behavior Therapy, Body Weight, Diet, Energy Metabolism, Female, Humans, Insulin Resistance, Insulin-Like Growth Factor I, Middle Aged, Neuropeptide Y, Obesity, Biomarkers, Weight Gain, Weight Loss, Peptide YY, Leptin, Adiponectin, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review